The performance of companies tied to Sildenafil's legacy presents a complex investment picture . While the initial success generated substantial gains, generic alternatives have significantly diminished https://thebookmarkfree.com/story21730242/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture